News
APYX
1.320
-4.35%
-0.060
Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive
Simply Wall St · 2d ago
Weekly Report: what happened at APYX last week (0408-0412)?
Weekly Report · 5d ago
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
The Renuvion Users’ Summit is taking place in Las Vegas from April 12-13, 2024. The Summit brings together professionals in cosmetic and plastic surgery from 13 countries to share new research, applications and clinical experiences with the Company’s Renvion technology. Apyx Medical Corporation is the manufacturer of a helium plasma and radiofrequency technology marketed and sold asRenuvion.
Barchart · 04/11 06:30
12 Health Care Stocks Moving In Tuesday's After-Market Session
Jaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. ATyr Pharma shares rose 10.45% and Corvus Pharma shares increased by 7.36%. Apyx Medical shares declined by 6.1% during the session.
Benzinga · 04/09 20:31
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), LifeMD (LFMD) and Apyx Medical (APYX)
TipRanks · 04/09 13:10
Weekly Report: what happened at APYX last week (0401-0405)?
Weekly Report · 04/08 09:18
CONSTANTINOS CHRISTOFILIS REPORTS 9.96% STAKE IN APYX MEDICAL CORP AS OF MARCH 29, 2024 - SEC FILING
Reuters · 04/05 13:04
Analysts Are Bullish on These Healthcare Stocks: Tandem Diabetes Care (TNDM), Apyx Medical (APYX)
TipRanks · 04/02 13:00
Craig-Hallum Releases a Buy Rating on Apyx Medical (APYX)
TipRanks · 04/02 12:45
STAVROS VIZIRGIANAKIS-BELIEVES RECENT TRADING PRICES OF APYX STOCK DO NOT ADEQUATELY REFLECT POTENTIAL VALUE OF APYX’S UNDERLYING BUSINESS, ASSETS
Reuters · 04/01 20:19
STAVROS VIZIRGIANAKIS- DESIRES TO ENGAGE WITH MANAGEMENT, BOARD OF APYX TO DISCUSS NUMEROUS ISSUES FACING APYX TODAY AND IN THE NEAR FUTURE
Reuters · 04/01 20:19
STAVROS G. VIZIRGIANAKIS REPORTS 5.04% STAKE IN APYX MEDICAL CORP AS OF MARCH 25- SEC FILING
Reuters · 04/01 20:19
STAVROS VIZIRGIANAKIS- WOULD LIKE TO WORK WITH MANAGEMENT AND BOARD OF APYX TO CONDUCT STRATEGIC REVIEW OF ALL COMMERCIAL ACTIVITIES
Reuters · 04/01 20:19
Weekly Report: what happened at APYX last week (0325-0329)?
Weekly Report · 04/01 09:18
Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates
Analysts have downgraded their forecasts for Apyx Medical Corporation (NASDAQ:APYX) for this year and 2024. Both revenue and earnings per share estimates for the business have been cut sharply. The consensus price target fell 22% to US$3.63 following the latest downgrade. The analysts also downgraded revenue estimates, with a 4.6% reduction in sales over the past 12 months.
Simply Wall St · 03/26 10:12
Weekly Report: what happened at APYX last week (0318-0322)?
Weekly Report · 03/25 09:18
Lake Street Reaffirms Their Buy Rating on Apyx Medical (APYX)
TipRanks · 03/22 13:05
Analysts Offer Insights on Healthcare Companies: Apyx Medical (APYX) and OKYO Pharma Limited Sponsored ADR (OKYO)
TipRanks · 03/22 13:00
Apyx Medical Insiders Lose Out As Stock Sinks To US$1.32
Insiders bought US$84.0k worth of Apyx Medical Corporation's stock over the last year. The company has seen a 22% decrease in its share price. In the last 12 months the average insider purchase price is US$1.60. Apyx medical insiders own 13% of the company. The price of a company's shares is important to consider. You can see the insider transactions at apyx medical over the years.
Simply Wall St · 03/22 10:35
Apyx Medical (APYX) Receives a Hold from JMP Securities
TipRanks · 03/22 04:35
More
Webull provides a variety of real-time APYX stock news. You can receive the latest news about Apyx Medical Corporation through multiple platforms. This information may help you make smarter investment decisions.
About APYX
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.